Moffitt Cancer Center
Tampa, FL USA

Our News on Newswise

Moffitt Cancer Center Researchers Develop New Way to Combat Drug Resistance for Melanoma Patients

Moffitt Cancer Center researchers developed a new way to identify possible therapeutic targets for patients with drug resistant melanoma. It involves using liquid chromatography-multiple reaction monitoring mass spectrometry to measure biomarkers or...
30-Jun-2014 11:00 AM EDT

Involving a Genetic Health Care Professional May Improve Quality, Reduce Unnecessary Testing

A new Moffitt Cancer Center study published Thursday in Genetics in Medicine shows that counseling from a genetic health care provider before genetic testing educates patients and may help reduce unnecessary procedures.
13-Jun-2014 10:00 AM EDT

Moffitt Cancer Center Researchers Develop Process to Help Personalize Treatment for Lung Cancer Patients

Moffitt Cancer Center researchers, in collaboration with the Lung Cancer Mutation Consortium, have developed a process to analyze mutated genes in lung adenocarcinoma to help better select personalized treatment options for patients. Adenocarcinoma...
3-Jun-2014 12:05 PM EDT

Moffitt Cancer Center Instrumental in New Clinical Guidelines for Cancer-Related Fatigue

Fatigue is a debilitating problem for cancer patients undergoing treatment; however, it also poses a huge detriment after treatment and can significantly affect quality of life. Approximately 30 percent of cancer patients endure persistent fatigue...
30-May-2014 3:00 PM EDT

Ohio State and Moffitt Form World’s Largest Cancer Research Collaboration for Big Data; More Than 100,000 Patients Already Participating

Two of North America’s leading cancer centers, Moffitt Cancer Center and The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC-James), today announced what is...
30-May-2014 10:00 AM EDT

Moffitt Cancer Center’s Phase 3 Study May Be Game-Changer for Acute Myeloid Leukemia

Moffitt Cancer Center researchers say clinical trials for a new experimental drug to treat acute myeloid leukemia (AML) are very promising. Patients treated with CPX-351, a combination of the chemotherapeutic drugs cytarabine and daunorubicin, are...
24-Apr-2014 8:00 AM EDT

Moffitt Cancer Center Begins Phase I Clinical Trial of New Immunotherapy

Moffitt Cancer Center has initiated a phase I clinical trial for a new immunotherapy drug, ID-G305, made by Immune Design. Immunotherapy is a treatment option that uses a person’s own immune system to fight cancer. It has several advantages over...
10-Apr-2014 8:00 AM EDT

Researchers Discover New Mechanism Allowing Tumor Cells to Escape Immune Surveillance

The immune system plays a pivotal role in targeting cancer cells for destruction. However, tumor cells are smart and have developed ways to avoid immune detection. A collaborative team of researchers at Moffitt Cancer Center recently discovered a...
18-Mar-2014 9:00 AM EDT

Our Experts on Newswise

Our experts are coming soon...

Our YouTube Videos